Mail & Guardian
Mail & Guardian
tuberculosis and malarialatest news & developments
HIV funding cuts fall hardest on key populations: sex workers, gay and bisexual men, transgender women and people who inject drugs — who have a much higher chance of getting HIV and depend heavily on specialised, donor-funded services which the government has been slow to take over. (Dylan Bush, Bhekisisa)

More HIV funding cuts are coming for SA. This time it’s a slow fade, but with clear risks

The Global Fund to Fight Aids, Tuberculosis and Malaria will start to cut its grant support to South Africa in just two years, with its final grant ending in eight years. Some…

To end Aids by 2043, the South African government says it could get a group of local pharmaceutical companies to make generic shots of lenacapavir from 2027 onwards. There is, however, a hitch. None of the companies that will be involved have a licence to make the jab. (Julia Koblitz/ Unsplash)

SA wants to make its own six-monthly HIV prevention jabs by 2027. But there’s a hitch

None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab

Newborn children in sub-Saharan Africa are 14 times more likely to die within the first month than those in high-income regions such as Australia and New Zealand.

Close the global healthcare gap: Solutions for a more equitable future

A comprehensive, multi-sector approach would help medical care in emerging countries catch up with those in more established nations

Abortion rights activists react after the Indiana Senate votes to ban abortion, inside the Indiana State house during a special session in Indianapolis. The legislature held a special session to ban abortion rights in the wake of the U.S. Supreme Court ruling overturning Roe v. Wade in June. Holcomb signed the bill into law. (Photo by Jeremy Hogan/SOPA Images/LightRocket via Getty Images)

WATCH: Could new abortion rules in the US affect the world’s biggest state HIV fund?

The US government has appointed the first African head of its Aids fund, Pepfar. John Nkengasong, a Cameroonian virologist

Aids group nixes new funds for Zimbabwe

An aid agency has decided against giving new healthcare funds to Zimbabwe to fight HIV/Aids until the country’s central bank returns -million.

Funding for Russia

The Global Fund to Fight Aids, Tuberculosis and Malaria has awarded Russia a two-year, $34,2- million grant for treatment.